XJPX
2475
Market cap198mUSD
Dec 05, Last price
1,571.00JPY
1D
-1.01%
1Q
-13.01%
Jan 2017
13.84%
IPO
935.26%
Name
WDB Holdings Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WDB Holdings Co., Ltd. provides human resource services in Japan. The company offers placement and dispatching services for research and development in the biopharma and chemical sectors; and specified dispatching services for research and development in the engineering sectors. It also provides safety information management support services; data management and statistical analysis for clinical trials/post marketing surveillance; and consulting services and dossier preparation for product-registrarion services. In addition, the company offers clinical trial services in pharmacovigilance and analytics; clinical monitoring, data management, statistical analysis, and safety information management support services; research and development services in drug discovery research; and custom synthetic services for drug discovery research. Further, it develops and manufactures an assortment of devices, including gas-assist injection molding machines, nitrogen generators, and bio-related devices. WDB Holdings Co., Ltd. was founded in 1985 and is headquartered in Himeji, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||